Kanada - angielski - Health Canada

ratiopharm inc division of teva canada limited - orciprenaline sulfate - syrup - 2mg - orciprenaline sulfate 2mg - selective beta 2-adrenergic agonists

Kanada - angielski - Health Canada

apotex inc - orciprenaline sulfate - syrup - 2mg - orciprenaline sulfate 2mg - selective beta 2-adrenergic agonists

Kanada - angielski - Health Canada

aa pharma inc - orciprenaline sulfate - syrup - 2mg - orciprenaline sulfate 2mg - selective beta 2-adrenergic agonists

Kanada - angielski - Health Canada

tanta pharmaceuticals inc - orciprenaline sulfate - syrup - 2mg - orciprenaline sulfate 2mg - selective beta 2-adrenergic agonists

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

boehringer ingelheim (nz) ltd - orciprenaline sulfate 2 mg/ml - syrup - 10 mg/5ml - active: orciprenaline sulfate 2 mg/ml

Kanada - angielski - Health Canada

nu-pharm inc - salbutamol (salbutamol sulfate) - solution - 2mg - salbutamol (salbutamol sulfate) 2mg - selective beta 2-adrenergic agonists

Australia - angielski - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 0.48 mg/ml (equivalent: salbutamol, qty 0.4 mg/ml) - oral liquid - excipient ingredients: sodium benzoate; hypromellose; citric acid monohydrate; sodium chloride; purified water; sodium citrate dihydrate; saccharin sodium; flavour - indications as at 14 february 2005: ventolin is indicated for the prevention and relief of bronchospasm in bronchial asthma of all types and for the alleviation of any reversible airways obstruction associated with conditions such as chronic bronchitis or emphysema.

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

boehringer ingelheim (nz) ltd - orciprenaline sulfate 20mg - tablet - 20 mg - active: orciprenaline sulfate 20mg

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

boehringer ingelheim (nz) ltd - orciprenaline sulfate 0.225 g (per container, 0.75mg/dose) - aerosol inhaler, metered dose - 0.75 mg/dose - active: orciprenaline sulfate 0.225 g (per container, 0.75mg/dose) excipient: cryofluorane dichlorodifluoromethane phosphatidylcholines, soya, hydrogenated trichlorofluoromethane

Kanada - angielski - Health Canada

boehringer ingelheim (canada) ltd ltee - orciprenaline sulfate - syrup - 10mg - orciprenaline sulfate 10mg - selective beta 2-adrenergic agonists